
Cagrilintide and Semaglutide: Why Researchers Combined Amylin and GLP-1
CagriSema combines the amylin analogue cagrilintide with the GLP-1 agonist semaglutide. Here is why researchers paired them, what human trials found, and what the evidence does not establish.
Read Article

